Intravitreal Triamcinolone Acetonide in Diabetic Macular Edema

Dr. Kabita Bora Baishya ^[3] | Dr. Suprio Kumar Datta

Abstract: Diabetic retinopathy (DR) is the most common microvascular complication of diabetes. The most common cause of vision loss in diabetic retinopathy is diabetic macular edema. Intravitreal injection of corticosteroids (triamcinolone acetonide), constitutes a newer, less destructive treatment modality in the management of diabetic macular edema. . Intravitreal triamcinolone acetonide is a favourable and promising therapeutic tool in managing diffuse diabetic macular oedema for certain duration of time with minimal transient side effect.

Keywords: Diabetic macular edema, OCT, intravitreal triamcinolone acetonide

Edition: Volume 7 Issue 10, October 2018,

Pages: 915 - 919

How to Download this Article?

Type Your Valid Email Address below to Receive the Article PDF Link

Verification Code will appear in 2 Seconds ... Wait

Intravitreal Triamcinolone Acetonide in Diabetic Macular Edema

Similar Articles with Keyword 'OCT'

Ketoacidosis as the First Presentation of Type 1 Diabetes Mellitus in Children and Adolescents during the Period 2010-2014 in Albania

In World First Transplant; A Man Received Genetically-Modified Pig Heart